{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:42:29Z","timestamp":1764700949793,"version":"3.41.2"},"reference-count":34,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Integr. Neurosci."],"abstract":"<jats:p>Background: In recent years, an overlapping syndrome, MNOS, of MOG encephalomyelitis and NMDARE has been clinically identified. In these diseases, both MOG-Ab and NMDAR-Ab are positive. Previous studies were almost case reports and incomprehensive which focused on this kind of overlapping syndrome in adults. Methods: We reported a rare case of MNOS. In addition, we reviewed the clinical characteristics, diagnosis, and treatment of MNOS in adults by consulting relevant literature. Results: The patient initially presented with CNS demyelination symptoms followed by recurrent encephalitis, concomitant anti-MOG, and NMDAR antibodies. His symptoms improved significantly after initiating hormonal therapy. We searched previous MNOS case reports and 17 adult MNOS cases were retrieved. The previous history of all patients was unremarkable. Most of these patients (72.2%, 13\/18) first developed NMDR encephalitis-related symptoms, such as cognitive behavior abnormalities, cognitive decline, and epilepsy. Some patients (16.7%, 3\/18) first developed MOG-related demyelinating symptoms, such as visual deterioration, walking instability, and dizziness. The most common site of new brain lesions was the supratentorial region. In the acute phase, MNOS patients were sensitive to hormone therapy. During the follow-up, 72.2% (13\/18) of the patients relapsed, with a median interval of 12.25 months. Immunotherapy was still effective after recurrence, and no deaths were reported. Conclusions: (1) The clinical manifestations of MNOS are atypical, sometimes like MOG encephalomyelitis, sometimes like NMDARE, sometimes both of the characteristic clinical manifestations are present. (2) Immunotherapy is the primary treatment of patients with MNOS. (3) MNOS are prone to recurrence, and serum MOG and tumor markers should be monitored.<\/jats:p>","DOI":"10.31083\/j.jin2103082","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T09:30:31Z","timestamp":1649928631000},"source":"Crossref","is-referenced-by-count":12,"title":["Relapsing MOG-IgG-associated diseases coexisting with anti-NMDAR encephalitis: a case report and literature review"],"prefix":"10.31083","volume":"21","author":[{"given":"Mengmeng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Hospital of Dalian Medical University, 116027 Dalian, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Hospital of Dalian Medical University, 116027 Dalian, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyang","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Hospital of Dalian Medical University, 116027 Dalian, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Hospital of Dalian Medical University, 116027 Dalian, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira Yerima","family":"Bako","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Second Hospital of Dalian Medical University, 116027 Dalian, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoqiang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Yantian District People's Hospital, 518000 Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhong","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Hospital of Dalian Medical University, 116027 Dalian, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"O\u2019Connor KC, McLaughlin KA, De Jager PL, Chitnis T, Bettelli E, Xu C, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nature Medicine. 2007; 13: 211\u2013217.","DOI":"10.1038\/nm1488"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. Journal of Neuroinflammation. 2018; 15: 134.","DOI":"10.1186\/s12974-018-1144-2"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Titulaer MJ, H\u00f6ftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al. Overlapping demyelinating syndromes and anti\u2013N-methyl-D-aspartate receptor encephalitis. Annals of Neurology. 2014; 75: 411\u2013428.","DOI":"10.1002\/ana.24117"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, et al. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Multiple Sclerosis and Related Disorders. 2018; 20: 144\u2013152.","DOI":"10.1016\/j.msard.2018.01.007"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Dalmau J. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse. Neurology. 2016; 87: 2471\u20132482.","DOI":"10.1212\/WNL.0000000000003414"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Malviya M, Barman S, Golombeck KS, Planagum\u00e0 J, Mannara F, Strutz-Seebohm N, et al. NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody. Annals of Clinical and Translational Neurology. 2017; 4: 768\u2013783.","DOI":"10.1002\/acn3.444"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hara M, Martinez-Hernandez E, Arino H, Armangue T, Spatola M, Petit-Pedrol M, et al. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor. Neurology. 2018; 90: e1386\u2013e1394.","DOI":"10.1212\/WNL.0000000000005329"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Ehrenreich H. Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease. Current Opinion in Neurology. 2018; 31: 306\u2013312.","DOI":"10.1097\/WCO.0000000000000546"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurology. 2016; 15: 391\u2013404.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ren Y, Chen X, He Q, Wang R, Lu W. Co-occurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Anti-myelin Oligodendrocyte Glycoprotein Inflammatory Demyelinating Diseases: A Clinical Phenomenon to Be Taken Seriously. Frontiers in Neurology. 2019; 10: 1271.","DOI":"10.3389\/fneur.2019.01271"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Zhou L, ZhangBao J, Li H, Li X, Huang Y, Wang M, et al. Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies. Multiple Sclerosis and Related Disorders. 2017; 18: 90\u201392.","DOI":"10.1016\/j.msard.2017.09.023"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Titulaer MJ, H\u00f6ftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al. Overlapping demyelinating syndromes and anti\u2013N-methyl-D-aspartate receptor encephalitis. Annals of Neurology. 2014; 75: 411\u2013428.","DOI":"10.1002\/ana.24117"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"P\u00e9rez CA, Agyei P, Gogia B, Harrison R, Samudralwar R. Overlapping autoimmune syndrome: a case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease. Journal of Neuroimmunology. 2020; 339: 577124.","DOI":"10.1016\/j.jneuroim.2019.577124"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Kaneko K, Sato DK, Misu TA, Kurosawa K, Nakashima I, Fujihara K, et al. Overlapping demyelinating syndromes and anti\u2013N-methyl-D-aspartate receptor encephalitis. Annals of Neurology. 2014; 75: 411\u2013428.","DOI":"10.1002\/ana.24117"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Zhou J, Tan W, Tan SE, Hu J, Chen Z, Wang K. An unusual case of anti-MOG CNS demyelination with concomitant mild anti-NMDAR encephalitis. Journal of Neuroimmunology. 2018; 320: 107\u2013110.","DOI":"10.1016\/j.jneuroim.2018.03.019"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Nagata S, Nishimura Y, Mitsuo K. A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis. Rinsho Shinkeigaku. 2018; 58: 636\u2013641.","DOI":"10.5692\/clinicalneurol.cn-001194"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Rojc B, Podnar B, Graus F. A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies. Journal of Neuroimmunology. 2019; 328: 86\u201388.","DOI":"10.1016\/j.jneuroim.2018.12.003"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Aoe S, Kokudo Y, Takata T, Kobara H, Yamamoto M, Touge T, et al. Repeated anti-N-methyl-D-aspartate receptor encephalitis coexisting with anti-myelin oligodendrocyte glycoprotein antibody-associated diseases: a case report. Multiple Sclerosis and Related Disorders. 2019; 35: 182\u2013184.","DOI":"10.1016\/j.msard.2019.08.002"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Cherian A, Divya KP, Shetty SC, Kannoth S, Thomas B. Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate. Multiple Sclerosis and Related Disorders. 2020; 46: 102468.","DOI":"10.1016\/j.msard.2020.102468"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Fujimori J, Takahashi T, Kaneko K, Atobe Y, Nakashima I. Anti-NMDAR encephalitis may develop concurrently with anti-MOG antibody-associated bilateral medial frontal cerebral cortical encephalitis and relapse with elevated CSF IL-6 and CXCL13. Multiple Sclerosis and Related Disorders. 2020; 47: 102611.","DOI":"10.1016\/j.msard.2020.102611"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Mathey E, Breithaupt C, Schubart A, Linington C. Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire. European Journal of Immunology. 2004; 34: 2065\u20132071.","DOI":"10.1002\/eji.200425291"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, et al. International multicenter examination of MOG antibody assays. Neurology Neuroimmunology & Neuroinflammation. 2020; 7: e674.","DOI":"10.1212\/NXI.0000000000000674"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Annals of Neurology. 2005; 58: 594\u2013604.","DOI":"10.1002\/ana.20614"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu H, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology. 2007; 61: 25\u201336.","DOI":"10.1002\/ana.21050"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurology. 2008; 7: 1091\u20131098.","DOI":"10.1016\/S1474-4422(08)70224-2"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Castillo-G\u00f3mez E, Oliveira B, Tapken D, Bertrand S, Klein-Schmidt C, Pan H, et al. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class. Molecular Psychiatry. 2017; 22: 1776\u20131784.","DOI":"10.1038\/mp.2016.125"},{"key":"ref27","unstructured":"Gong S, Zhang W H, Ren H T, Li J W, Zhou J, Cheng H, et al. Clinical observation on the overlapping syndrome of myelin oligodendrocyte glycoprotein antibody and anti-N-methyl-D aspartate receptor in children. Zhonghua Er Ke Za Zhi. 2020; 58: 581\u2013585. (In Chinese)"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Xu X, Lu Q, Huang Y, Fan S, Zhou L, Yuan J, et al. Anti-NMDAR encephalitis. Neurology Neuroimmunology & Neuroinflammation. 2020; 7: e633.","DOI":"10.1212\/NXI.0000000000000633"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Gabilondo I, Saiz A, Gal\u00e1n L, Gonz\u00e1lez V, Jadraque R, Sabater L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology. 2011; 77: 996\u2013999.","DOI":"10.1212\/WNL.0b013e31822cfc6b"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Journal of Neuroinflammation. 2016; 13: 279.","DOI":"10.1186\/s12974-016-0717-1"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Journal of Neuroinflammation. 2016; 13: 280.","DOI":"10.1186\/s12974-016-0718-0"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. Journal of Neuroinflammation. 2016; 13: 281.","DOI":"10.1186\/s12974-016-0719-z"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. Journal of Neuroinflammation. 2016; 13: 282.","DOI":"10.1186\/s12974-016-0720-6"},{"key":"ref34","unstructured":"Zheng J, Shen J, Wang A, Liu L, Xiong J, Li X, et al. Clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis in children. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020; 45: 47\u201354. (In Chinese)"}],"container-title":["Journal of Integrative Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/21\/3\/10.31083\/j.jin2103082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T15:41:04Z","timestamp":1732722064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/21\/3\/10.31083\/j.jin2103082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"alternative-id":["S0219-6352(22)00342-4"],"URL":"https:\/\/doi.org\/10.31083\/j.jin2103082","relation":{},"ISSN":["0219-6352","1757-448X"],"issn-type":[{"type":"print","value":"0219-6352"},{"type":"electronic","value":"1757-448X"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"article-number":"82"}}